MedTrace Logo

Effect of Central Venous Catheter Dressing Types on Device-Related Pressure Injuries

NCT07437040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effect of different central venous catheter dressing methods on the development of medical device-related pressure injuries in participants treated in the intensive care unit.

This study aims to answer the following questions:

* What is the risk of pressure injury development in participants whose catheter dressings are performed using gauze and adhesive tape?
* What is the risk of pressure injury development in participants whose catheter dressings are performed using a chlorhexidine gluconate-containing transparent dressing?
* Is there a difference between these two dressing methods in terms of pressure injury development?

The researchers will compare participants receiving gauze and adhesive tape dressings with participants receiving chlorhexidine gluconate-containing transparent dressings.

Participants will:

* Receive catheter dressings according to the assigned dressing method based on randomization.
* Undergo regular catheter site assessments.
* Be evaluated for pressure injury development through skin assessments.
* Have their pressure injury risk monitored using the Braden Pressure Injury Risk Assessment Scale.

Conditions

  • Pressure Injuries
  • Medical Device Related Pressure Ulcer (MDRPU)

Interventions

DEVICE

Gauze Dressing

Central venous catheter dressing performed using sterile gauze and adhesive tape.

DEVICE

Chlorhexidine Gluconate Transparent Dressing

Central venous catheter dressing performed using chlorhexidine gluconate-impregnated transparent dressing.

Sponsors & Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

    lead OTHER

Principal Investigators

  • Hilal Uysal, PhD · Bartın University, Department of Internal Medicine Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-10
Primary Completion
2022-12-10
Completion
2022-12-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07437040 on ClinicalTrials.gov